Potential role of purinergic signaling in lithium-induced nephrogenic diabetes insipidus

American Journal of Physiology - Renal Physiology

Volumn 296, Issue 5, 2009, Pages

  Zhang, Yue ^a   Nelson, Raoul D ^b   Carlson, Noel G ^a   Kamerath, Craig D ^a   Kohan, Donald E ^a   Kishore, Bellamkonda K ^a,c  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c VA SCL Health Care System   (United States)

Author keywords

Bipolar disorder; Collecting duct; Cyclooxygenases; Extracellular nucleotides; Neurodegeneration; P2 receptors; Prostaglandin E2; Rat

Indexed keywords

ADENOSINE 5' O (3 THIOTRIPHOSPHATE); ADENOSINE DIPHOSPHATE; AQUAPORIN 2; BETA ACTIN; LITHIUM; PROSTAGLANDIN E2; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; URIDINE TRIPHOSPHATE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KIDNEY COLLECTING TUBULE; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 66049102560     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90774.2008     Document Type: Article

References (57)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jackobson KA, Weisman GA. International Union of Pharmacology. LVIII. Update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341, 2006.
2. Allen HM, Jackson RL, Winchester MD, Deck LV, Allon M. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Arch Intern Med 149: 1123-1126, 1989. (Pubitemid 19131838)
3. Baldessarini RJ, Pompili M, Tondo L. Suicide in bipolar disorder. Risks and management. CNS Spectr 11: 465-471, 2006.
4. 2 and arthritis. Arthritis Rheum 36: 190-198, 1993.
5. Bonvalet JP, Pradelles P, Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol Renal Fluid Electrolyte Physiol 253: F377-F387, 1987. (Pubitemid 18073133)
6. Bravo R, Egger SS, Crespo S, Probst WL, Krahenbuhl S. Lithium intoxication as a result of interaction with rofecoxib. Ann Pharmacother 38: 1189-1193, 2004.
7. Breyer MB, Breyer RM. Prostaglandin E receptors and the kidney. Am J Physiol Renal Physiol 279: F12-F23, 2000.
8. Bucheimer RE, Linden J. Purinergic regulation of epithelial transport. J Physiol 555: 311-321, 2004. (Pubitemid 38379992)
9. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87: 659-797, 2007. (Pubitemid 47084682)
10. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger AP, Masón MR, Hamm HE. Insights into G protein structure, function, and regulation. Endocr Rev 24: 765-781, 2003. (Pubitemid 38067698)
11. Carlson NG, Hill KE, Tsunoda I, Fujinami RS, Rose JW. The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis. J Neuroimmunol 174: 21-31, 2006.
12. Chuang DM. Neuroprotective and neurotropic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases? Crit Rev Neurobiol 16: 83-90, 2004.
13. De Vries L, Zheng B, Fisher T, Elenko E, Farquar MG. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol 40: 235-271, 2000. (Pubitemid 30340681)
14. Ecelbarger CA, Maeda Y, Gibson CC, Knepper MA. Extracellular ATP increases intracellular calcium in rat terminal collecting duct via a nucleotide receptor. Am J Physiol Renal Fluid Electrolyte Physiol 267: F998-F1006, 1994. (Pubitemid 124005381)
15. Fenton RA, Knepper MA. Mouse model and the urinary concentrating mechanism in the new millennium. Physiol Rev 87: 1083-1112, 2008.
16. Frölich JC, Leftwich R, Ragheb M, Oates JA, Reimann I, Buchanan D. Indomethacin increases plasma lithium. Br Med J 1: 1115-1116, 1979. (Pubitemid 9153237)
17. Fujimura A, Ohashi K, Ebihara A. Influence of repeated administration of lithium on urinary excretion of prostaglandins in rats. Jpn J Pharmacol 57: 565-569, 1991.
18. Gitlin M. Lithium and the kidney: an update review. Drug Saf 20: 231-243, 1994.
19. Han JS, Maeda Y, Ecelbarger C, Knepper MA. Vasopressin-independent regulation of collecting duct water permeability. Am J Physiol Renal Fluid Electrolyte Physiol 266: F139-F146, 1994. (Pubitemid 2045894)
20. Hermans E. Biochemical and pharmacological control of the multiplicity of coupling at G protein-coupled receptors. Pharmacol Ther 99: 25-44, 2003. (Pubitemid 36694748)
21. Hill KE, Zollinger LV, Watt HE, Carlson NG, Rose JW. Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage. J Neuroimmunol 151: 171-179, 2004.
22. Hirabayashi T, Shimizu T. Localization and regulation of cytosolic phospholipase A2. Biochim Biophys Acta 1488: 124-138, 2000.
23. Judge JP, Kohan DE, Carlson NG, Nelson RD, Kishore BK. Mice with genetic deletion of P2Y2 receptor are markedly resistant to lithium-induced polyuria (Abstract). J Am Soc Nephrol 17: 31A, 2006.
24. Kishore BK, Carlson NG, Kamareth CD, Zhang Y. Potential involvement of P2Y2 and P2Y4 receptors in lithium-induced polyuria (Abstract). J Am Soc Nephrol 19: 582A, 2008.
25. Kishore BK, Carlson NG, Raoul RD, Kohan DE. Renal purinergic system - a potential drug target for the treatment of lithium-induced diabetes insipidus (Abstract). Purinergic Signal 4: S100, 2008.
26. Kishore BK, Chou CL, Knepper MA. Extracellular nucleotide receptor inhibits AVP-stimulated water permeability in inner medullary collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 269: F863-F869, 1995.
27. Kishore BK, Ginns SM, Krane CM, Nielsen S, Knepper MA. Cellular localization of P2Y2 purinoceptor in rat inner medulla and lung. Am J Physiol Renal Physiol 278: F43-F51, 2000. (Pubitemid 30106124)
28. Kishore BK, Krane CM, Miller RL, Shi H, Zhang P, Hemmert A, Sun R, Nelson RD. P2Y2 receptor mRNA and protein expression is altered in inner medullas of hydrated and dehydrated rat: relevance to AVP-independent regulation of IMCD function. Am J Physiol Renal Physiol 288: F1164-F1172, 2005. (Pubitemid 40677086)
29. Kishore BK, Krane CM, Reif M, Menon AG. Molecular physiology of urinary concentration defect in elderly population. Int Urol Nephrol 33: 235-248, 2001. (Pubitemid 34575371)
30. Kotnik P. Altered expression of COX-1, COX-2, and mPEGS in rats with nephrogenic and central diabetes insipidus. Am J Physiol Renal Physiol 288: F1053-F1068, 2005. (Pubitemid 40569771)
31. + transporters in rats with lithium-induced NDI. Am J Physiol Renal Physiol 279: F552-F564, 2000.
32. Leipziger J. Control of epithelial transport via luminal P2 receptors. Am J Physiol Renal Physiol 284: F419-F432, 2003. (Pubitemid 36227903)
33. Lenox RH, McNamara RK, Papke RL, Manji HK. Neurobiology of lithium. J Clin Psychiatry 58: 37-47, 1998.
34. Luckey AE, Parsa CJ. Fluid and electrolytes in the aged. Arch Surg 138:1055-1060, 2003.
35. Manji HK, Moore GJ, Chen G. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 46: 929-940, 1999.
36. Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 95: 1935-11845, 1995. (Pubitemid 3020680)
37. 2 inhibitors as potential anti-inflammatory agents. Curr Pharm Des 11: 1301-1312, 2005.
38. Mitchell PB, Malhi GS. Emerging drugs for bipolar disorders. Expert Opin Emerg Drugs 11: 621-634, 2006.
39. Murray MD, Brater DC. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu Rev Pharmacol Toxicol 32: 435-465, 1993.
40. 2 inhibits water permeability at a post-cAMP site in rat terminal inner medullary collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 262: F229-F235, 1992.
41. Phelan KM, Mosholder AD, Lu S. Lithium interaction with the cyclooxygenase-2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry 64: 1328-1334, 2003. (Pubitemid 37490238)
42. Rao R, Zhang MZ, Zhao M, Cai H, Harris RC, Breyer MD, Hao CM. Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria. Am J Physiol Renal Physiol 288: F642-F649, 2005.
43. 2α reduced urea absorption from the rat collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 241: F53-F60, 1981.
44. +, and urea transport in rat inner medullary collecting duct. Am J Physiol Renal Physiol 279: F294-F301, 2000.
45. Rowe MK, Chuang DM. Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Rev Mol Med 18: 1-18, 2004.
46. Schwiebert EM. ATP release mechanisms, ATP receptors and purinergic signaling along the nephron. Clin Exp Pharmacol Physiol 28: 340-350, 2001.
47. Schwiebert EM, Kishore BK. Extracellular nucleotide signaling along the renal epithelium. Am J Physiol Renal Physiol 280: F945-F963, 2001.
48. 2, cAMP, and vasopressin in lithium-induced polyuria. Am J Physiol Regul Integr Comp Physiol 254: R863-R869, 1988.
49. 2 by medullary collecting duct is altered in hydrated and dehydrated rats: relevance to AVP-independent regulation of IMCD function. Am J Physiol Renal Physiol 289: F585-F592, 2005.
50. 2 by IMCD. Am J Physiol Renal Physiol 289: F769-F776, 2005.
51. 2 release from the medullary collecting duct of rats with acquired nephrogenic diabetes insipidus. Pathophysiological and therapeutic implications (Abstract). FASEB J 19: A58, 2005.
52. Vallon V. P2 receptors in the regulation of renal transport mechanisms. Am J Physiol Renal Physiol 294: F10-F27, 2008.
53. Wada A, Yokoo H, Yanagita T, Kobayashi H. Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases. J Pharmacol Sci 99: 307-321, 2005. (Pubitemid 41813422)
54. 2 by rat inner medullary collecting duct preparations. Am J Physiol Renal Physiol 285: F711-F721, 2003.
55. Wildman SSP, Marks J, Turner CM, Yew-Booth L, Peppiate-Wildman CM, King BF, Shirley DG, Wang W, Unwin RJ. Sodium-dependent regulation of amiloride sensitive currents by apical P2 receptors. J Am Soc Nephrol 19: 731-742, 2008.
56. 2 interaction with AVP: effect of AQP2 phosphorylation and distribution. Am J Physiol Renal Physiol 278: F338-F394, 2000.
57. Zhang Y, Sands JM, Kohan DE, Nelson RD, Martin CF, Carlson NG, Kamerath CD, Ge Y, Klein JD, Kishore BK. Potential role of purinergic signaling in urinary concentration in inner medulla: insights from P2Y2 receptor gene knockout mice. Am J Physiol Renal Physiol 295: F1715-F1724, 2008.